Stryker (SYK) Cash & Current Investments (2009 - 2026)
Stryker's (SYK) quarterly Cash & Current Investments came in at $3.5 billion in Q2 2026, up 41.07% year-over-year from $2.5 billion in Q2 2025, and up 17.23% quarter-over-quarter from $3.0 billion in Q1 2026.
Analysis
Stryker (SYK) Cash & Current Investments (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Cash & Current Investments for 18 consecutive years, with $3.5 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash & Current Investments rose 41.07% year-over-year to $3.5 billion in Q2 2026; TTM through Jun 2026 was $3.5 billion, a 41.07% increase from a year earlier, with the FY2025 full-year figure at $4.1 billion, down 6.86% from the prior year.
- Cash & Current Investments was $3.5 billion for Q2 2026 at Stryker, up from $3.0 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $4.6 billion in Q3 2024 and troughed at $1.1 billion in Q2 2022.
- A 5-year average of $2.6 billion and a median of $2.4 billion in 2024 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments plunged 51.53% in 2022 and jumped 137.6% in 2024, its largest moves.
- Over 5 years, Cash & Current Investments stood at $1.9 billion in 2022, then jumped by 58.35% to $3.1 billion in 2023, then jumped by 44.19% to $4.4 billion in 2024, then fell by 6.86% to $4.1 billion in 2025, then fell by 15.22% to $3.5 billion in 2026.
- The last three Cash & Current Investments figures came in at $3.5 billion (Q2 2026), $3.0 billion (Q1 2026), and $4.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.48 Bn |
| Mar 31, 2026 | 2.97 Bn |
| Dec 31, 2025 | 4.10 Bn |
| Sep 30, 2025 | 3.34 Bn |
| Jun 30, 2025 | 2.46 Bn |
| Mar 31, 2025 | 2.41 Bn |
| Dec 31, 2024 | 4.40 Bn |
| Sep 30, 2024 | 4.60 Bn |
| Jun 30, 2024 | 1.96 Bn |
| Mar 31, 2024 | 2.41 Bn |
| Dec 31, 2023 | 3.05 Bn |
| Sep 30, 2023 | 1.94 Bn |
| Jun 30, 2023 | 1.48 Bn |
| Mar 31, 2023 | 1.76 Bn |
| Dec 31, 2022 | 1.93 Bn |
| Sep 30, 2022 | 1.50 Bn |
| Jun 30, 2022 | 1.13 Bn |
| Mar 31, 2022 | 1.53 Bn |
| Dec 31, 2021 | 3.02 Bn |
| Sep 30, 2021 | 2.64 Bn |